Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03468218Phase 2Active Not Recruiting
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
Metastatic Head and Neck CarcinomaParanasal Sinus Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma+21 more
PrincipalinvestigatorStart date: 2018-09-18
NCT03521570Phase 2Completed
Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
Recurrent Head and Neck Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2018-06-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Athanassios (Ethan) Argiris

ECOG-ACRIN Cancer Research Group

Related
2 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

George Blumenschein, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Paul M Harari

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Hassan Arshad

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Renata Ferrarotto

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Steven J Frank

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Periasamy Selvaraj, PhD

Metaclipse Therapeutics

Related
1 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell Carcinoma
Similarity Score1%

Arya Amini

City of Hope Medical Center

Related
7 trials

Shared therapeutic areas:

Metastatic Head and Neck Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Tanguy Seiwert

University of Chicago Comprehensive Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Clifton D Fuller

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Unresectable Head and Neck Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03468218Phase 2PrincipalInvestigator

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Metastatic Head and Neck CarcinomaParanasal Sinus Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma+21 more
Active Not Recruiting
NCT03521570Phase 2PrincipalInvestigator

Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer

Recurrent Head and Neck Squamous Cell Carcinoma
Completed

All 2 trials loaded